Delivery Order SPE2DB20D1100-SPE2DB24FC8X3

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,504.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Zolmitriptan 2.5 mg nasal spray in packages of 6, with a completion date of February 17, 2023. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,698,068 units of Zolmitriptan 5 mg nasal spray, with a ceiling value of $1,024.85. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,586.72 Firm Fixed Price Delivery Order covers the supply of Zolmitriptan 5 mg Nasal Spray. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $11,212.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zolmitriptan 5 mg nasal spray, a medical product used for the treatment of migraines. The contract has an ultimate completion date of July 10, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA), a defense agency. The $2,042.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $62,444.36 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, a medication used to treat migraines. The contract has a completion date of July 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,741,631 units of Zolmitriptan 5 mg nasal spray, with a ceiling value of $4,918.74. The contract is a firm fixed-price delivery order, with a period of performance through May 30, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of Zolmitriptan 5 mg nasal spray. The $66,221.88 firm fixed-price delivery order has a completion date of January 24, 2025. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB24FFK02) valued at $7,151.56 for the supply of Zolmitriptan 5 mg nasal spray. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 1, 2024. The contract is a firm fixed-price, indefinite delivery/indefinite quantity (IDIQ) vehicle that allows the DLA to efficiently procure a wide range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,818.40 firm fixed-price delivery order is for the supply of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a prescription medication. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC8X3
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Zolmitriptan 5 mg nasal spray. The contract has a ceiling value of $5,884.97 and a completion date of July 24, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing medications, syringes, vials, and test kits across multiple therapeutic areas. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 9:58 AM